Concepedia

Author

Jeremy A. Yethon

University of Guelph

Also Known As

J. yethon, Jeremy A. Yethon, Jeremy Yethon

19

Publications

1.9K

Citations

15

H-Index

30

Concepts

All Affiliations

University of GuelphSanofi (United States)Institute for Biological SciencesKing Abdulaziz UniversityBrigham and Women's Hospital
JA

About

Jeremy A. Yethon is an author at University of Guelph specializing in medicine, structural biology, and glycobiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

512

2

Biochemistry

3

3

117

3

Natural Sciences

2

2

24

4

Engineering

1

1

93

5

Biomolecular Engineering

1

1

29

Jeremy A. Yethon

×

14

Publications

1.4K

Citations

12

H-Index

YearCitations

A mucosal vaccine against <i>Chlamydia trachomatis</i> generates two waves of protective memory T cells

Georg Stary, Andrew J. Olive, Aleksandar F. Radovic‐Moreno,

Science

2015

366

Interaction with a Membrane Surface Triggers a Reversible Conformational Change in Bax Normally Associated with Induction of Apoptosis

Jeremy A. Yethon, Raquel F. Epand, Brian Leber,

Journal of Biological Chemistry

2003

200

Involvement of waaY, waaQ, and waaP in the Modification of Escherichia coliLipopolysaccharide and Their Role in the Formation of a Stable Outer Membrane

Jeremy A. Yethon, David E. Heinrichs, Mário A. Monteiro,

Journal of Biological Chemistry

1998

195

Mutation of the Lipopolysaccharide Core Glycosyltransferase Encoded by <i>waaG</i> Destabilizes the Outer Membrane of <i>Escherichia coli</i> by Interfering with Core Phosphorylation

Jeremy A. Yethon, Evgeny Vinogradov, Malcolm B. Perry,

Journal of Bacteriology

2000

134

Mode of Action, <i>In Vitro</i> Activity, and <i>In Vivo</i> Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor

Nachum Kaplan, Monique Albert, Donald E. Awrey,

Antimicrobial Agents and Chemotherapy

2012

109

<i>Salmonella enterica</i> Serovar Typhimurium <i>waaP</i> Mutants Show Increased Susceptibility to Polymyxin and Loss of Virulence In Vivo

Jeremy A. Yethon, John S. Gunn, Robert K. Ernst,

Infection and Immunity

2000

97

The Assembly System for the Outer Core Portion of R1- and R4-type Lipopolysaccharides of Escherichia coli

David E. Heinrichs, Jeremy A. Yethon, Paul A. Amor,

Journal of Biological Chemistry

1998

93

Purification and Characterization of WaaP from Escherichia coli, a Lipopolysaccharide Kinase Essential for Outer Membrane Stability

Jeremy A. Yethon, Chris Whitfield

Journal of Biological Chemistry

2001

45

<i>In vitro</i>activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics

Nachum Kaplan, Donald E. Awrey, Elias Bardouniotis,

Journal of Chemotherapy

2013

31

Structure-guided Antigen Engineering Yields Pneumolysin Mutants Suitable for Vaccination against Pneumococcal Disease

E.O. Oloo, Jeremy A. Yethon, Martina M. Ochs,

Journal of Biological Chemistry

2011

29

Page 1